MLchartDataset catalogue

rubitecan

Term · Oncology and biomedicine · MLC-T-ONC-016597

A semisynthetic agent related to camptothecin with potent antitumor and antiviral properties. Rubitecan binds to and inhibits the enzyme topoisomerase I and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells; this agent also prevents repair of reversible single-strand DNA breaks.

Table 1. Record
IdentifierMLC-T-ONC-016597
FieldOncology and biomedicine
Abbreviation9-NC
Synonyms9-nitro-CPT; 9-nitrocamptothecin; nitrocamptothecin
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016597",
  "term": "rubitecan",
  "field": "Oncology and biomedicine",
  "definition": "A semisynthetic agent related to camptothecin with potent antitumor and antiviral properties. Rubitecan binds to and inhibits the enzyme topoisomerase I and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells; this agent also prevents repair of reversible single-strand DNA breaks.",
  "abbreviation": "9-NC",
  "synonyms": [
    "9-nitro-CPT",
    "9-nitrocamptothecin",
    "nitrocamptothecin"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/rubitecan/"
}

Record 14,605 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.